New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
13:20 EDTINCYIncyte June volatility elevated into ASCO
Incyte June call option implied volatility is at 79, July is at 60, September is at 58, compared to its 26-week average of 64 according to Track Data, suggesting large near term price movement into discussion of RESPONSE: Phase 3 Trial of Ruxolitinib in PV at ASCO.
News For INCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 13, 2015
07:34 EDTINCYIncyte, Merck expand clinical partnership towards Phase 3 Keytruda study
Subscribe for More Information
October 2, 2015
07:31 EDTINCYIncyte to present new data on immuno-oncology portfolio at SITC
Subscribe for More Information
October 1, 2015
07:31 EDTINCYLeerink to hold a roundtable
Subscribe for More Information
September 30, 2015
08:30 EDTINCYIncyte to join Nasdaq-100 Index beginning Oct. 7, to replace Altera
Nasdaq yesterday announced that Incyte Corporation (INCY), will become a component of the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index prior to market open on Wednesday, October 7, 2015. Incyte Corporation will replace Altera Corporation (ALTR). Incyte Corporation is headquartered in Palo Alto, California, and has a market capitalization of approximately $19B.
September 29, 2015
06:47 EDTINCYEli Lilly and Incyte's baricitinib Phase 3 study met primary objective
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use